Singapore markets closed

Coherus BioSciences, Inc. (CHRS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
2.0400+0.1100 (+5.70%)
At close: 04:00PM EDT
2.0118 -0.03 (-1.38%)
After hours: 07:09PM EDT
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-237,892
-237,892
-291,754
-287,100
132,244
Depreciation & amortisation
3,791
3,791
3,699
3,454
2,888
Stock-based compensation
43,110
43,110
50,737
51,364
38,160
Change in working capital
-36,826
-36,826
-79,257
42,360
-34,651
Accounts receivable
-150,683
-150,683
13,052
34,062
-15,218
Inventory
-46,734
-46,734
-47,348
-6,253
-38,359
Accounts payable
23,760
23,760
-4,548
874
-9,820
Other working capital
-175,170
-175,170
-243,163
-38,721
146,914
Other non-cash items
3,390
3,390
43,959
143,052
13,333
Net cash provided by operating activities
-174,884
-174,884
-241,124
-37,432
154,145
Cash flows from investing activities
Investments in property, plant and equipment
-286
-286
-2,039
-1,289
-7,231
Acquisitions, net
-
-
-
-
0
Purchases of investments
-19,507
-19,507
-127,382
-182,485
-273,845
Sales/maturities of investments
157,642
157,642
0
181,364
274,000
Other investing activities
-1,051
-1,051
-37,429
-136,000
-7,500
Net cash used for investing activities
144,640
144,640
-166,850
-138,410
-14,401
Cash flows from financing activities
Debt repayment
0
0
-190,750
0
0
Common stock issued
71,718
71,718
6,358
40,903
0
Other financing activities
-4,621
-4,621
-4,972
-2,425
-19,439
Net cash used provided by (used for) financing activities
69,600
69,600
54,326
51,879
223,946
Net change in cash
39,356
39,356
-353,648
-123,963
363,690
Cash at beginning of period
63,987
63,987
417,635
541,598
177,908
Cash at end of period
103,343
103,343
63,987
417,635
541,598
Free cash flow
Operating cash flow
-174,884
-174,884
-241,124
-37,432
154,145
Capital expenditure
-286
-286
-2,039
-1,289
-7,231
Free cash flow
-175,170
-175,170
-243,163
-38,721
146,914